• Study Comparing Ipilimumab and Nivolumab to Nivolumab Alone for Patients with Resectable Stage III Melanoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

    Recruiting

    3 1
    Investigated diseases:
    Portugal Spain
  • Study on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain
  • Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on the Safety of CNTY-101 and Aldesleukin for Patients with Active Autoimmune Diseases: Lupus, Scleroderma, and Myositis

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study on the Safety and Effectiveness of Emicizumab for Patients with Type 3 Von Willebrand Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Poland +2
  • Study on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8
  • Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Croatia Czechia Estonia Germany +6
  • Study on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Denmark Finland France Germany Greece +6
  • Study on the Safety and Effects of Rapcabtagene Autoleucel, Tocilizumab, Fludarabine Phosphate, and Cyclophosphamide for Patients with Rheumatoid Arthritis and Sjogren’s Disease

    Recruiting

    1 1 1 1
    France Germany Hungary Italy Spain

powered by